In The News
Coles, Woolworths hit with class actions over discount claims
‘Very surprising’: ASIC slams payday lender’s argument on appeal
Parties race to settle Exactech joint implant class action
Uber accused of refusing rides for blind passenger at Melbourne Airport
Telstra did not discriminate by standing down Triple-0 worker with hearing loss: court
Insurer Marsh breached obligation in case over $7B Greensill collapse: court
Novartis loses case against Pharmacor over blood pressure drug
MinRes admits it should have disclosed related-party transactions
High Court says church not vicariously liable for historic abuse
Social media companies to face new duty of care regulations
Please login to bookmarkClose

Samsung Bioepis can’t get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug. 

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au